LEBWOHL, M.; WARREN, R. B.; IMAFUKU, S.; BAGEL, J.; ARMSTRONG, A. W.; PASSERON, T.; BANERJEE, S.; COLOMBO, M. J.; SCHARNITZ, T.; HOYT, K.; THACI, D.; BLAUVELT, A. Deucravacitinib Long-Term Efficacy Through 4 years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 4, p. s408, 2024. DOI: 10.25251/skin.8.supp.408. Disponível em: https://jofskin.org/index.php/skin/article/view/2872. Acesso em: 23 jul. 2024.